Recent Advances in Imaging of Pancreatic Neoplasms

  • Chad B. Rabinowitz
  • Hima B. Prabhakar
  • Dushyant V. Sahani
Part of the Cancer Treatment and Research book series (CTAR, volume 143)

Oncologic imaging of the pancreas is a challenging entity due to a large number of primary pancreatic neoplasms, as well as benign entities of the pancreas that simulate neoplasms, such as inflammatory and cystic disease. While clinical and laboratory data are able to distinguish many of the disease processes affecting the pancreas, imaging is inevitably tied to diagnosis and treatment, given the significant overlap of patient symptoms in benign and malignant pancreatic disorders. In general primary pancreatic neoplasms can be divided into three categories: solid, cystic and neuroendocrine tumors. All three of these can overlap in common imaging findings, and familiarity with available imaging modalities can help differentiate these tumors from benign disease. This chapter will discuss current and emerging techniques in pancreatic imaging, as well as their integration with oncologic care.


Pancreatic Cancer Optical Coherence Tomography Chronic Pancreatitis Pancreatic Duct Pancreatic Neoplasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007 Jan-Feb;57(1):43–66.PubMedGoogle Scholar
  2. 2.
    Lowenfels AB, Maisonneuve P. Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol. 2004 May;34(5):238–44.PubMedGoogle Scholar
  3. 3.
    Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993;328:1433–7.PubMedGoogle Scholar
  4. 4.
    Lowenfels AB, Maisonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst.1997;89:442–6PubMedGoogle Scholar
  5. 5.
    Spinelli KS, Fromwiller TE, Daniel RA, et al. Cystic pancreatic neoplasms: observe or operate. Ann Surg. 2004 May;239(5):651–7.PubMedGoogle Scholar
  6. 6.
    Tada M, Kawabe T, Arizumi M, et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol. 2006 Oct;4(10):1265–70.PubMedGoogle Scholar
  7. 7.
    Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001 May;25(5):579–86.PubMedGoogle Scholar
  8. 8.
    Maitra A, Adsay NV, Argani P, et al. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol. 2003 Sep;16(9):902–12.PubMedGoogle Scholar
  9. 9.
    Kimura W, Nagai H, Kuroda A, Muto T, Esaki Y. Analysis of small cystic lesions of the pancreas. Int J Pancreatol. 1995 Dec;18(3):197–206.PubMedGoogle Scholar
  10. 10.
    Zhang XM, Mitchell DG, Dohke M, Holland GA, Parker L. Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology. 2002 May;223(2):547–53.PubMedGoogle Scholar
  11. 11.
    Brugge WR. Cystic pancreatic lesions: can we diagnose them accurately? What to look for. FNA marker molecular analysis resection, surveillance, or endoscopic treatment? Endoscopy. 2006 Jun;38 Suppl 1:S40–7.Google Scholar
  12. 12.
    Sahani DV, Kadavigere R, Saokar A, Fernandez-del Castillo C, Brugge WR, Hahn PF. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics. 2005 Nov-Dec;25(6):1471–84.PubMedGoogle Scholar
  13. 13.
    Nichols MT, Russ PD, Chen YK. Pancreatic imaging: current and emerging technologies. Pancreas. 2006 Oct;33(3):211–20.PubMedGoogle Scholar
  14. 14.
    Bronstein YL, Loyer EM, Kaur H, et al. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol. 2004 Mar;182(3):619–23.PubMedGoogle Scholar
  15. 15.
    Ariyama J, Suyama M, Satoh K, Sai J. Imaging of small pancreatic ductal adenocarcinoma. Pancreas. 1998 Apr;16(3):396–401.PubMedGoogle Scholar
  16. 16.
    Manoharan P, Sheridan M B. Neoplasms of the Pancreas. Imaging 2004. (16): 323–337.Google Scholar
  17. 17.
    Mergo PJ, Helmberger TK, Buetow PC, Helmberger RC, Ros PR. Pancreatic neoplams: MR imaging and pathologic correlation. Radiographics. 1997 Mar-Apr;17(2):281–301.PubMedGoogle Scholar
  18. 18.
    Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med. 2006 Dec 21;355(25):2670–6PubMedGoogle Scholar
  19. 19.
    Sahani DV, Kalva SP, Farrell J, et al. Autoimmune pancreatitis: imaging features. Radiology. 2004 Nov;233(2):345–52.PubMedGoogle Scholar
  20. 20.
    Brugge WR, Lauwers GY, Sahani D, Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. N Engl J Med. 2004 Sep 16;351(12):1218–26.PubMedGoogle Scholar
  21. 21.
    Kawamoto S, Lawler LP, Horton KM, Eng J, Hruban RH, Fishman EK. MDCT of intraductal papillary mucinous neoplasm of the pancreas: evaluation of features predictive of invasive carcinoma. AJR Am J Roentgenol. 2006 Mar;186(3):687–95.PubMedGoogle Scholar
  22. 22.
    Sahani DV, Saokar A, Hahn PF, Brugge WR, Fernandez-Del Castillo C. Pancreatic cysts 3 cm or smaller: how aggressive should treatment be? Radiology. 2006 Mar;238(3):912–9.PubMedGoogle Scholar
  23. 23.
    Megibow AJ, Lombardo FP, Guarise A, et al. Cystic pancreatic masses: cross-sectional imaging observations and serial follow-up. Abdom Imaging. 2001 Nov-Dec;26(6): 640–7.PubMedGoogle Scholar
  24. 24.
    Allen PJ, Jaques DP, D’Angelica M, Bowne WB, Conlon KC, Brennan MF. Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg. 2003 Dec;7(8):970–7.PubMedGoogle Scholar
  25. 25.
    Duraker N, Hot S, Polat Y, Hobek A, Gencler N, Urhan N. CEA, CA 19–9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice. J Surg Oncol. 2007 Feb 1;95(2):142–7.PubMedGoogle Scholar
  26. 26.
    Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19–9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2006 Nov 8; [Epub ahead of print].Google Scholar
  27. 27.
    Albert MB, Steinberg WM, Henry JP. Elevated serum levels of tumor marker CA19–9 in acute cholangitis. Dig Dis Sci. 1988 Oct;33(10):1223–5.PubMedGoogle Scholar
  28. 28.
    Schima W, Ba-Ssalamah A, Kolblinger C, Kulinna-Cosentini C, Puespoek A, Gotzinger P. Pancreatic adenocarcinoma. Eur Radiol. 2007 Mar;17(3):638–49.PubMedGoogle Scholar
  29. 29.
    Leach SD, Lee JE, Charnsangavej C, et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg. 1998 May;85(5):611–7.PubMedGoogle Scholar
  30. 30.
    Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006 Jul;244(1):10–5.PubMedGoogle Scholar
  31. 31.
    Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993 Jan;165(1):68–72.PubMedGoogle Scholar
  32. 32.
    Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol. 1997 Jun;168(6):1439–43.PubMedGoogle Scholar
  33. 33.
    O’Malley ME, Boland GW, Wood BJ, Fernandez-del Castillo C, Warshaw AL, Mueller PR. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am J Roentgenol. 1999 Dec;173(6):1513–8.PubMedGoogle Scholar
  34. 34.
    Li H, Zeng MS, Zhou KR, Jin DY, Lou WH. Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion. J Comput Assist Tomogr. 2005 Mar-Apr;29(2):170–5.PubMedGoogle Scholar
  35. 35.
    Li H, Zeng MS, Zhou KR, Jin DY, Lou WH. Pancreatic adenocarcinoma: signs of vascular invasion determined by multi-detector row CT. Br J Radiol. 2006 Nov;79(947):880–7.PubMedGoogle Scholar
  36. 36.
    Kalser MH, Barkin J, MacIntyre JM. Pancreatic cancer. Assessment of prognosis by clinical presentation. Cancer. 1985 Jul 15;56(2):397–402.PubMedGoogle Scholar
  37. 37.
    Vogt DP. Pancreatic cancer: a current overview. Curr Surg. 2000 May 1;57(3):214–220.PubMedGoogle Scholar
  38. 38.
    Reber HA. Small pancreatic tumors: Is size an indication of curability? J hepatobiliary Pancreat Surg 1995; 2(4): 384–386.Google Scholar
  39. 39.
    Spencer MP, Sarr MG, Nagorney DM. Radical pancreatectomy for pancreatic cancer in the elderly. Is it safe and justified? Ann Surg. 1990 Aug;212(2):140–3.PubMedGoogle Scholar
  40. 40.
    Farrell JJ. Diagnosing pancreatic malignancy in the setting of chronic pancreatitis: is there room for improvement? Gastrointest Endosc. 2005 Nov;62(5):737–41.PubMedGoogle Scholar
  41. 41.
    Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc. 2005 Nov;62(5):728–36.PubMedGoogle Scholar
  42. 42.
    Volmar KE, Vollmer RT, Jowell PS, Nelson RC, Xie HB. Pancreatic FNA in 1000 cases: a comparison of imaging modalities. Gastrointest Endosc. 2005 Jun;61(7):854–61.PubMedGoogle Scholar
  43. 43.
    Horwhat JD, Paulson EK, McGrath K, et al. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions. Gastrointest Endosc. 2006 Jun;63(7):966–75.PubMedGoogle Scholar
  44. 44.
    Erturk SM, Mortele KJ, Tuncali K, Saltzman JR, Lao R, Silverman SG. Fine-needle aspiration biopsy of solid pancreatic masses: comparison of CT and endoscopic sonography guidance. AJR Am J Roentgenol. 2006 Dec;187(6):1531–5.PubMedGoogle Scholar
  45. 45.
    Micames C, Jowell PS, White R, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA versus percutaneous FNA. Gastrointest Endosc. 2003 Nov;58(5):690–5.PubMedGoogle Scholar
  46. 46.
    Ichikawa T, Sou H, Araki T, et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology. 2001 Oct;221(1):107–16.PubMedGoogle Scholar
  47. 47.
    Stefanidis D, Grove KD, Schwesinger WH, Thomas CR Jr. The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review. Ann Oncol. 2006 Feb;17(2):189–99.PubMedGoogle Scholar
  48. 48.
    Fernandez-del Castillo C, Warshaw AL. Laparoscopy for staging in pancreatic carcinoma. Surg Oncol. 1993;2 Suppl 1:25–9.PubMedGoogle Scholar
  49. 49.
    Liu RC, Traverso LW. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc. 2005. May; 19(5):638–42.PubMedGoogle Scholar
  50. 50.
    Ichikawa T, Erturk SM, Sou H, et al. MDCT of Pancreatic Adenocarcinoma: Optimal Imaging Phases and Multiplanar Reformatted Imaging. AJR Am J Roentgenol. Dec 2006 (187): 1513–1520.PubMedGoogle Scholar
  51. 51.
    Morganti AG, Brizi MG, Macchia G, et al. The prognostic effect of clinical staging in pancreatic adenocarcinoma.Ann Surg Oncol. 2005 Feb;12(2):145–51.PubMedGoogle Scholar
  52. 52.
    Schueller G, Schima W, Schueller-Weidekamm C, et al. Multidetector CT of pancreas: effects of contrast material flow rate and individualized scan delay on enhancement of pancreas and tumor contrast. Radiology. 2006 Nov;241(2):441–8.PubMedGoogle Scholar
  53. 53.
    Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology. 2002 Sep;224(3): 764–8.PubMedGoogle Scholar
  54. 54.
    Semelka RC, Kelekis NL, Molina PL, Sharp TJ, Calvo B. Pancreatic masses with inconclusive findings on spiral CT: is there a role for MRI? J Magn Reson Imaging. 1996 Jul-Aug;6(4):585–8.PubMedGoogle Scholar
  55. 55.
    Raptopoulos V, Steer ML, Sheiman RG, Vrachliotis TG, Gougoutas CA, Movson JS. The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: correlation with findings at surgery. AJR Am J Roentgenol. 1997 Apr;168(4):971–7.PubMedGoogle Scholar
  56. 56.
    Ellsmere J, Mortele K, Sahani D, et al. Does multidetector-row CT eliminate the role of diagnostic laparoscopy in assessing the resectability of pancreatic head adenocarcinoma? Surg Endosc. 2005 Mar;19(3):369–73.PubMedGoogle Scholar
  57. 57.
    Vargas R, Nino-Murcia M, Trueblood W, Jeffrey RB Jr. MDCT in Pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 2004 Feb;182(2):419–25.PubMedGoogle Scholar
  58. 58.
    Legmann P, Vignaux O, Dousset B, et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol. 1998 May;170(5):1315–22.PubMedGoogle Scholar
  59. 59.
    Ichikawa T, Haradome H, Hachiya J, et al. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology. 1997 Mar;202(3):655–62.PubMedGoogle Scholar
  60. 60.
    Grenacher L, Klauss M, Dukic L, et al. Diagnosis and staging of pancreatic carcinoma: MRI versus multislice-CT–a prospective study. Rofo. 2004 Nov;176(11):1624–33.PubMedGoogle Scholar
  61. 61.
    DeWitt J, Devereaux B, Chriswell M, McGreevy, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med. 2004 Nov 16;141(10):753–63.PubMedGoogle Scholar
  62. 62.
    Curry CA, Eng J, Horton KM, et al. CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment? AJR Am J Roentgenol. 2000 Jul;175(1):99–103.PubMedGoogle Scholar
  63. 63.
    Kim SY, Lee JM, Kim SH, et al. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor. AJR Am J Roentgenol. 2006 Nov;187(5):1192–8.PubMedGoogle Scholar
  64. 64.
    Kang CM, Park SH, Kim KS, Choi JS, Lee WJ, Kim BR. Surgical experiences of functioning neuroendocrine neoplasm of the pancreas. Yonsei Med J. 2006 Dec 31; 47(6):833–9.PubMedGoogle Scholar
  65. 65.
    Van Hoe L, Gryspeerdt S, Marchal G, Baert AL, Mertens L. Helical CT for the preoperative localization of islet cell tumors of the pancreas: value of arterial and parenchymal phase images. AJR Am J Roentgenol. 1995 Dec;165(6):1437–9.PubMedGoogle Scholar
  66. 66.
    Rappeport ED, Hansen CP, Kjaer A, Knigge U. Multidetector computed tomography and neuroendocrine pancreaticoduodenal tumors. Acta Radiol. 2006 Apr;47(3):248–56.PubMedGoogle Scholar
  67. 67.
    Gouya H, Vignaux O, Augui J, Dousset B, Palazzo L, Louvel A, et al. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol. 2003 Oct;181(4):987–92.PubMedGoogle Scholar
  68. 68.
    King CM, Reznek RH, Dacie JE, Wass JA. Imaging islet cell tumours. Clin Radiol. 1994 May;49(5):295–303.PubMedGoogle Scholar
  69. 69.
    Sodickson A, Mortele KJ, Barish MA, et al. Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques. Radiology. 2006; 238(2):549–59.PubMedGoogle Scholar
  70. 70.
    Hellerhoff KJ, Helmberger H 3rd, Rosch T, et al. Dynamic MR pancreatography after secretin administration: image quality and diagnostic accuracy. AJR Am J Roentgenol. 2002; 179(1):121–9.PubMedGoogle Scholar
  71. 71.
    Ichikawa T, Erturk SM, Motosugi U, et al. High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results. AJR Am J Roentgenol. 2007 Feb;188(2):409–14.PubMedGoogle Scholar
  72. 72.
    Erturk SM, Ichikawa T, Sou H, et al. Pancreatic Adenocarcinoma: MDCT Versus MRI in the Detection and Assessment of Locoregional Extension. JCAT 2006; 30(4):583–590.Google Scholar
  73. 73.
    Holalkere NS, Sahani DV, Blake MA, Halpern EF, Hahn PF, Mueller PR. Characterization of small liver lesions: Added role of MR after MDCT. J Comput Assist Tomogr. 2006 Jul-Aug;30(4):591–6.PubMedGoogle Scholar
  74. 74.
    Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology. 1999 Jan;210(1):71–4.PubMedGoogle Scholar
  75. 75.
    Schima W, Fugger R, Schober E, et al. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR Am J Roentgenol. 2002 Sep;179(3):717–24.PubMedGoogle Scholar
  76. 76.
    Dromain C, de Baere T, Lumbroso J, et al. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol. 2005 Jan 1;23(1):70–8.PubMedGoogle Scholar
  77. 77.
    Higashi T, Saga T, Nakamoto Y, et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET)–usefulness and limitations in “clinical reality”. Ann Nucl Med. 2003 Jun;17(4):261–79.PubMedGoogle Scholar
  78. 78.
    Orlando LA, Kulasingam SL, Matchar DB. Meta-analysis: the detection of pancreatic malignancy with positron emission tomography. Aliment Pharmacol Ther. 2004 Nov 15;20(10):1063–70.PubMedGoogle Scholar
  79. 79.
    Rosenbaum SJ, Stergar H, Antoch G, Veit P, Bockisch A, Kuhl H. Staging and follow-up of gastrointestinal tumors with PET/CT. Abdom Imaging. 2006 Jan-Feb;31(1):25–35PubMedGoogle Scholar
  80. 80.
    Lemke AJ, Niehues SM, Hosten N, et al. Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions–a prospective study with 104 patients. J Nucl Med. 2004 Aug;45(8):1279–86.PubMedGoogle Scholar
  81. 81.
    Ruf J, Lopez Hanninen E, Bohmig M, et al. Impact of FDG-PET/MRI Image Fusion on the Detection of Pancreatic Cancer. Pancreatology. 2006 Nov 13;6(6):512–519.PubMedGoogle Scholar
  82. 82.
    Diederichs CG, Staib L, Vogel J, et al. Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas. 2000 Mar; 20(2):109–16.PubMedGoogle Scholar
  83. 83.
    Frohlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN. Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med. 1999 Feb;40(2):250–5.PubMedGoogle Scholar
  84. 84.
    Sahani DV, Kalva SP, Fischman AJ, et al. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol. 2005 Jul;185(1):239–46.PubMedGoogle Scholar
  85. 85.
    Yang M, Martin DR, Karabulut N, Frick MP. Comparison of MR and PET imaging for the evaluation of liver metastases. J Magn Reson Imaging. 2003 Mar;17(3):343–9.PubMedGoogle Scholar
  86. 86.
    Yoshioka M, Sato T, Furuya T, et al. Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer. J Gastroenterol. 2004 Jan;39(1):50–5.PubMedGoogle Scholar
  87. 87.
    Maisey NR, Webb A, Flux GD, et al. FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. J Cancer. 2000 Aug;83(3):287–93.Google Scholar
  88. 88.
    Bang S, Chung HW, Park SW, et al. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer. J Clin Gastroenterol. 2006 Nov-Dec;40(10):923–9.PubMedGoogle Scholar
  89. 89.
    Rose DM, Delbeke D, Beauchamp RD, et al. 18Fluorodeoxyglucose-positron emission tomo graphy in the management of patients with suspected pancreatic cancer. Ann Surg. 1999 May;229(5):729–37.PubMedGoogle Scholar
  90. 90.
    Lyshchik A, Higashi T, Nakamoto Y, et al. Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):389–97.PubMedGoogle Scholar
  91. 91.
    Nishiyama Y, Yamamoto Y, Monden T, et al. Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour. Nucl Med Commun. 2005 Oct;26(10):895–901.PubMedGoogle Scholar
  92. 92.
    Been LB, Suurmeijer AJ, Cobben DC, Jager PL, Hoekstra HJ, Elsinga PH. [18F]FLT-PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging. 2004 Dec;31(12):1659–72.PubMedGoogle Scholar
  93. 93.
    van Waarde A, Jager PL, Ishiwata K, Dierckx RA, Elsinga PH. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. J Nucl Med. 2006 Jan;47(1):150–4.PubMedGoogle Scholar
  94. 94.
    Mansour JC, Schwartz L, Pandit-Taskar N, et al. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. J Gastrointest Surg. 2006 Dec;10(10):1354–60.PubMedGoogle Scholar
  95. 95.
    Cronan JJ. Ultrasound: Is there a future in diagnostic imaging? JACR 2006; 3(9): 645–6.PubMedGoogle Scholar
  96. 96.
    Rickes S, Monkemuller K, Malfertheiner P. Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors. JOP. 2006 Nov 10;7(6):584–92.PubMedGoogle Scholar
  97. 97.
    Korpanty G, Carbon JG, Grayburn PA, Fleming JB, Brekken RA. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res. 2007 Jan 1;13(1):323–30.PubMedGoogle Scholar
  98. 98.
    Calculli L, Pezzilli R, Casadei R, Fiscaletti, et al. The imaging of pancreatic exocrine solid tumors: the role of computed tomography and positron emission tomography. JOP. 2007 Jan 9;8(1 Suppl):77–84.PubMedGoogle Scholar
  99. 99.
    Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol. 2006 Jun;4(6):717–25.PubMedGoogle Scholar
  100. 100.
    Klapman JB, Chang KJ, Lee JG, Nguyen P. Negative predictive value of endoscopic ultrasound in a large series of patients with a clinical suspicion of pancreatic cancer. Am J Gastroenterol. 2005 Dec;100(12):2658–61.PubMedGoogle Scholar
  101. 101.
    Alsibai KD, Denis B, Bottlaender J, Kleinclaus I, Straub P, Fabre M. Impact of cytopathologist expert on diagnosis and treatment of pancreatic lesions in current clinical practice. A series of 106 endoscopic ultrasound-guided fine needle aspirations. Cytopathology. 2006 Feb;17(1):18–26.PubMedGoogle Scholar
  102. 102.
    De Angelis C, Repici A, Carucci P, et al. Pancreatic cancer imaging: the new role of endoscopic ultrasound. JOP. 2007 Jan 9;8(1 Suppl):85–97.PubMedGoogle Scholar
  103. 103.
    Micames CG, Gress FG. Local EUS-guided injection of chemotherapeutic agents as adjuvant to systemic treatment: the first steps are made. Gastrointest Endosc. 2006 Dec 13; [Epub ahead of print].Google Scholar
  104. 104.
    Tran QN, Urayama S, Meyers FJ. Endoscopic ultrasound-guided celiac plexus neurolysis for pancreatic cancer pain: a single-institution experience and review of the literature. J Support Oncol. 2006 Oct;4(9):460–2, 464; discussion 463–4.PubMedGoogle Scholar
  105. 105.
    Wang PJ, Shang MY, Qian Z, Shao CW, Wang JH, Zhao XH. CT-guided percutaneous neurolytic celiac plexus block technique. Abdom Imaging. 2006 Dec 7; [Epub ahead of print].Google Scholar
  106. 106.
    Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol. 2000 Sep;95(9):2271–7.PubMedGoogle Scholar
  107. 107.
    Kwon RS, Scheiman JM. New advances in pancreatic imaging. Curr Opin Gastroenterol. 2006 Sep;22(5):512–9.PubMedGoogle Scholar
  108. 108.
    Fujita N, Noda Y, Kobayashi G, Kimura K, Ito K. Endoscopic approach to early diagnosis of pancreatic cancer. Pancreas. 2004 Apr;28(3):279–81.PubMedGoogle Scholar
  109. 109.
    Furukawa T, Tsukamoto Y, Naitoh Y, Hirooka Y, Hayakawa T. Differential diagnosis between benign and malignant localized stenosis of the main pancreatic duct by intraductal ultrasound of the pancreas. Am J Gastroenterol. 1994 Nov;89(11):2038–41.PubMedGoogle Scholar
  110. 110.
    Furukawa T, Oohashi K, Yamao K, et al. Intraductal ultrasonography of the pancreas: development and clinical potential. Endoscopy. 1997 Aug;29(6):561–9.PubMedGoogle Scholar
  111. 111.
    Testoni PA, Mariani A, Mangiavillano B, et al. Main pancreatic duct, common bile duct and sphincter of Oddi structure visualized by optical coherence tomography: An ex vivo study compared with histology. Dig Liver Dis. 2006 Jun;38(6):409–14.PubMedGoogle Scholar
  112. 112.
    Testoni PA, Mangiavillano B, Albarello L, et al. Optical coherence tomography to detect epithelial lesions of the main pancreatic duct: an Ex Vivo study. Am J Gastroenterol. 2005 Dec;100(12):2777–83.PubMedGoogle Scholar
  113. 113.
    Testoni PA, Mariani A, Mangiavillano B, Arcidiacono PG, Masci E. Preliminary data on the use of intraductal optical coherence tomography during ERCP for investigating main pancreatic duct strictures. Gut. 2006 Nov;55(11):1680–1.PubMedGoogle Scholar
  114. 114.
    Testoni PA, Mariani A, Mangiavillano B, Arcidiacono PG, Di Pietro S, Masci E. Intraductal Optical Coherence Tomography for Investigating Main Pancreatic Duct Strictures. Am J Gastroenterol 2007;102:269–274.PubMedGoogle Scholar
  115. 115.
    Roach PJ, Schembri GP, Ho Shon IA, Bailey EA, Bailey DL. SPECT/CT imaging using a spiral CT scanner for anatomical localization: Impact on diagnostic accuracy and reporter confidence in clinical practice. Nucl Med Commun. 2006 Dec;27(12):977–87.PubMedGoogle Scholar
  116. 116.
    Ingui CJ, Shah NP, Oates ME. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis. Clin Nucl Med. 2006 Nov;31(11):665–72.PubMedGoogle Scholar
  117. 117.
    Stabile BE, Morrow DJ, Passaro E Jr. The gastrinoma triangle: operative implications. Am J Surg. 1984 Jan;147(1):25–31.PubMedGoogle Scholar
  118. 118.
    Gibril F, Reynolds JC, Doppman JL, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med. 1996 Jul 1;125(1):26–34.PubMedGoogle Scholar
  119. 119.
    Montet X, Weissleder R, Josephson L. Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. Bioconjug Chem. 2006 Jul-Aug;17(4):905–11.PubMedGoogle Scholar
  120. 120.
    Fleischmann A, Laderach U, Friess H, Buechler MW, Reubi JC. Bombesin receptors in distinct tissue compartments of human pancreatic diseases. Lab Invest 2000. Dec;80(12):1807–17.PubMedGoogle Scholar
  121. 121.
    Rehman S, Jayson GC. Molecular imaging of antiangiogenic agents. Oncologist. 2005 Feb;10(2):92–103.PubMedGoogle Scholar
  122. 122.
    Miles KA, Hayball MP, Dixon AK. Measurement of human pancreatic perfusion using dynamic computed tomography with perfusion imaging. Br J Radiol. 1995 May;68(809):471–5.PubMedGoogle Scholar
  123. 123.
    Xue HD, Jin ZY, Liu W, Wang Y, Zhao WM. Perfusion characteristics of normal pancreas and insulinoma on multi-slice spiral CT. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Feb;28(1):68–70.PubMedGoogle Scholar
  124. 124.
    Kiessling F, Morgenstern B, Zhang C. Contrast agents and applications to assess tumor angiogenesis in vivo by magnetic resonance imaging. Curr Med Chem. 2007;14(1):77–91.PubMedGoogle Scholar
  125. 125.
    Johnson PT, Outwater EK. Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Radiology. 1999 Jul. 212(1):213–8.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Chad B. Rabinowitz
    • 1
  • Hima B. Prabhakar
    • 1
  • Dushyant V. Sahani
    • 1
  1. 1.Department of Abdominal Imaging and Interventional RadiologyMassachusetts General HospitalBostonUSA

Personalised recommendations